HWG Holdings’s TG Therapeutics TGTX Stock Holding History

HWG Holdings’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,200	Closed	-$116K	–	113
2017 Q4	$116K	Hold	14,200	–	–	0.1%	58
2017 Q3	$168K	Hold	14,200	–	–	0.13%	46
2017 Q2	$143K	Buy	+14,200	New	+$159K	0.11%	35

Other funds holding TGTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

HWG Holdings's TGTX Position: Q3 2017 in Review

HWG Holdings sold out of TG Therapeutics (TGTX) in Q3 2017, closing a stake of 1,132 shares — an estimated $12.9K sold.

HWG Holdings first reported a position in TGTX in Q4 2014 and held it in 4 quarters. The position peaked at $5.85M in Q4 2014. 101 funds tracked by Wall St. Rank hold TGTX as of Q3 2017.

HWG Holdings reported no remaining TG Therapeutics position as of Q3 2017 after selling out during the quarter.
HWG Holdings sold 1,132 TG Therapeutics shares in Q3 2017, an estimated $12.9K.
HWG Holdings first reported a position in TG Therapeutics in Q4 2014 and held it in 4 quarters.
HWG Holdings's TG Therapeutics position peaked at $5.85M in Q4 2014.
101 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2017.

Based on HWG Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.